Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 15;80(8):553-555.
doi: 10.1136/thorax-2024-221738.

Inherited predisposition to pneumothorax: estimating the frequency of Birt-Hogg-Dubé syndrome from genomics and population cohorts

Collaborators, Affiliations

Inherited predisposition to pneumothorax: estimating the frequency of Birt-Hogg-Dubé syndrome from genomics and population cohorts

Bryndis Yngvadottir et al. Thorax. .

Abstract

Birt-Hogg-Dubé syndrome (BHDS) is the most common monogenic cause of pneumothorax. Most affected families have pathogenic variants in the FLCN gene. Using large genomic registries (UK Biobank (UKB), 100,000 Genomes Project and East London Genes & Health) including >550 000 individuals, we demonstrate that the frequency of clinically validated loss-of-function FLCN variants is 1 in 2710 to 4190. While the lifetime risk of pneumothorax in FLCN mutation carriers in the UKB and a BHDS clinical cohort was substantial (28.4% and 37.3%, respectively, to age 65 years), the lifetime risk of renal cancer was significantly lower in UKB than in BHDS patients (1% vs 32.1%). These findings highlight the importance of clinical context in managing individuals with FLCN mutations.

Keywords: Pleural Disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. Age-related manifestations of Birt-Hogg-Dubé syndrome (BHDS). Kaplan-Meier survival curves (with 95% CI) for age-related risk of developing (A) pneumothorax and (B) renal cell carcinoma (RCC) in patients with BHDS with pathogenic loss-of-function FLCN mutations (blue line) versus UK Biobank participants with pathogenic loss-of-function FLCN mutations (red line).

References

    1. Birt AR, Hogg GR, Dubé WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol. 1977;113:1674–7. - PubMed
    1. Menko FH, van Steensel MAM, Giraud S, et al. Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol. 2009;10:1199–206. doi: 10.1016/S1470-2045(09)70188-3. - DOI - PubMed
    1. Nickerson ML, Warren MB, Toro JR, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell. 2002;2:157–64. doi: 10.1016/S1535-6108(02)00104-6. - DOI - PubMed
    1. Matsumoto K, Lim D, Pharoah PD, et al. A systematic review assessing the existence of pneumothorax-only variants of FLCN. Implications for lifelong surveillance of renal tumours. Eur J Hum Genet. 2021;29:1595–600. doi: 10.1038/s41431-021-00921-x. - DOI - PMC - PubMed
    1. Pavlovich CP, Grubb RL, Hurley K, et al. EVALUATION AND MANAGEMENT OF RENAL TUMORS IN THE BIRT-HOGG-DUBÉ SYNDROME. Journal of Urology. 2005;173:1482–6. doi: 10.1097/01.ju.0000154629.45832.30. - DOI - PubMed

Publication types

LinkOut - more resources